Literature DB >> 11793107

Vasculitis associated with septicemia: case report and review of the literature.

K Kodo1, M Hida, S Omori, T Mori, M Tokumura, S Kuramochi, M Awazu.   

Abstract

We report an unusual case in which infectious endocarditis presented systemic vasculitis and glomerulonephritis as the initial manifestation of the disease. The patient was a 16-year-old girl with congenital cyanotic heart disease who presented with skin purpura, proteinuria, and hematuria. She had hypergammaglobulinemia, cryoglobulinemia, and positive circulating immune complexes. Renal biopsy revealed crescentic glomerulonephritis. Her serum C3 level, which was initially normal, became decreased, and prednisolone and azathioprine were administered with a tentative diagnosis of systemic lupus erythematosus (SLE). Soon after, she developed fever and renal failure. Blood culture grew Streptococcus pyogenes, and the diagnosis of infectious endocarditis was made. Eight cases of systemic vasculitis and glomerulonephritis associated with infectious endocarditis have been described in the literature. Infectious endocarditis should be included in the differential diagnosis of systemic vasculitis and glomerulonephritis.

Entities:  

Mesh:

Year:  2001        PMID: 11793107     DOI: 10.1007/s004670100035

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  2 in total

1.  An Ineffective Differential Diagnosis of Infective Endocarditis and Rheumatic Heart Disease after Streptococcal Skin and Soft Tissue Infection.

Authors:  Tetsuya Suzuki; Momoko Mawatari; Toshihiko Iizuka; Tatsuya Amano; Satoshi Kutsuna; Yoshihiro Fujiya; Nozomi Takeshita; Kayoko Hayakawa; Norio Ohmagari
Journal:  Intern Med       Date:  2017-08-10       Impact factor: 1.271

2.  Bartonella Infectious Endocarditis Associated With Cryoglobulinemia and Multifocal Proliferative Glomerulonephritis.

Authors:  Ahmed Babiker; Mohammed I El Hag; Christian Perez
Journal:  Open Forum Infect Dis       Date:  2018-07-27       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.